Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Closed-End Fund
  • Objective: Dynamic Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: U.S.

Tekla Healthcare Opportunities Fund

+ Add to Watchlist

THQ:US

20.3100 USD 0.1500 0.74%

As of 20:04:05 ET on 03/02/2015.

Snapshot for Tekla Healthcare Opportunities Fund (THQ)

Open: 20.2100 High - Low: 20.3200 - 20.1000 Primary Exchange: New York
Volume: 172,743 52-Week Range: 16.5800 - 20.5700 Beta vs SPX: -

ETF Chart for THQ

No chart data available.
  • THQ:US 20.3100
  • 1D
  • 1M
  • 1Y
20.1600
Interactive THQ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for THQ

Tekla Healthcare Opportunities Fund is a closed-end fund incorporated in the USA. The Fund seeks current income and long-term capital appreciation. The Fund invests at least 80% of its managed assets in U.S. and non-U.S. companies engaged in the healthcare industry including equity securities, debt securities, and pooled investment vehicles.

Inception Date: 2014-07-29 Telephone: 1-617-772-8500
Managers: -
Web Site: www.teklacap.com

Fundamentals for THQ

NAV (on 2015-03-02) 22.0600
Assets (M) (on 2014-10-30) 895.4226
Shares out (M) 43.88
Market Cap (M) 891.17
% Premium -7.93
Average 52-Week % Premium -3.2459
Fund Leveraged N

Dividends for THQ

Dividend Type Income
Dividend Frequency Monthly
Last Dividend Net (on 2015-02-17) 0.1125
Dividend Yield (ttm) 3.32%

Performance for THQ

1-Month +2.12% 1-Year -
3-Month +3.26% 3-Year -
Year To Date +2.43% 5-Year -
Expense Ratio 1.28

Top Fund Holdings for THQ

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 652,819 69,492,582 8.193%
Celgene Corp 606,342 57,469,095 6.776%
Pfizer Inc 1,229,037 36,342,624 4.285%
Johnson & Johnson 327,212 34,877,527 4.112%
AbbVie Inc 481,219 27,795,210 3.277%
Illumina Inc 125,500 20,571,960 2.425%
Incyte Corp 373,723 18,331,113 2.161%
Teva Pharmaceutical Industries 340,718 18,313,593 2.159%
ARIA 3 ⅝ 06/15/19 21,030 17,082,863 2.014%
Bristol-Myers Squibb Co 332,640 17,024,515 2.007%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil